IP Library Granted Patent US 9,603,816
Granted Patent B2
US 9,603,816 · App. 14/132,221 · Granted Mar 28, 2017

Process

Inventors: Hans-Juergen Mair (Loerrach, DE); Reinhard Reents (Muenchenstein, CH); Michelangelo Scalone (Birsfelden, CH); Shaoning Wang (Basel, CH); Andreas Zogg (Frenkendorf, CH)
Assignee: Hoffmann-La Roche Inc.
A61K31/16A61K31/167C07C319/06C07C327/30C07C327/34C07D277/64C07C2101/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,603,816
App. No.
14/132,221
Granted
Mar 28, 2017
Kind
B2
Abstract

The present invention relates to a process for the preparation of S-[2-[1-(2 -ethylbutyl)cyclohexylcarbonylamino]-phenyl] 2-methylthiopropionate which is useful as a pharmaceutically active compound.

Claims (23)

1. A process for the preparation of a compound of formula (Ia):

wherein R 1 is a (C 1 -C 8 ) aryl, Which comprises reacting a compound of formula (II′):

wherein R is H or a compound of the formula:

with H 2 in the presence of (1) an acylating agent anhydride derivative [((C 1 -C 8 )alkyl)C(═O)] 2 or [aryl(C═O)] 2 O or a halide derivative ((C 1 -C 8 )alkyl)C(═O)halide or aryl(C═O) halide and (2) a heterogeneous transition metal hydrogenation catalyst.

2. A process for the preparation of a compound of formula (Ia) and Formula (X):

wherein R 1 is a (C 1 -C 8 ) aryl, Which comprises reacting a compound of formula (II′):

wherein R is H or a compound of the formula:

with H 2 in the presence of (1) an acylating agent anhydride derivative [((C 1 -C 8 )alkyl)C(═O)] 2 or [aryl(C═O)] 2 O or a halide derivative ((C 1 -C 8 )alkyl)C(═O)halide or aryl(C═O)halide and (2) a heterogeneous transition metal hydrogenation catalyst.

3. The process according to claim 2 , wherein R is:

4. The process according to claim 1 wherein R 1 is isopropyl and the acylating agent is isobutyric anhydride or isobutyryl halide.

5. The process according to claim 1 wherein the acylating agent is isobutyric anhydride.

6. The process according to claim 5 , wherein 2.0 to 4.0 equivalents of is obutyric anhydride with respect to the disulfide of formula (II′) is used.

7. The process according to claim 1 , wherein said process is performed in the presence of a solvent or a mixture of two or more solvents.

8. The process according to claim 7 , wherein the solvent is an organic solvent.

9. The process according to claim 7 , wherein the solvent is an ether like solvent, ester like solvent, aliphatic hydrocarbon solvent, saturated alicyclic hydrocarbon solvent, aromatic solvent or a mixture thereof.

10. The process according to claim 7 , wherein the solvent is an aliphatic hydrocarbon solvent, saturated alicyclic hydrocarbon solvent, or aromatic solvent.

11. ihe process according to claim 1 , wherein the acylatmg agent is an anhydride derivative which can act as a solvent or co-solvent with a molar ratio anhydride/amidodisulfide of 2 to 19.

12. The process according to claim 1 , wherein the H 2 is added at a pressure of at least 0.1 bar.

13. The process according to cliam 1 , wherein the reaction is carried out at temperature up to 150° C.

14. The process according to claim 1 , wherein the heterogeneous transition metal hydrogenation catalyst is a Raney catalyst, Pd/C, Pd(OH) 2 /C, Nanoparticulate Palladium(0) microencapsulated in polyurea matrix, Au/TiO 2 , Rh/C, Ru/Al 2 O 3 , Ir/CaCo 3 , Pt/C, or a mixture thereof.

15. The process according to claim 1 , wherein the heterogeneous transition metal hydrogenation catalyst is a Raney catalyst, Pd/C, Pd(OH) 2 /C, Au/TiO 2 , Rh/C, Ru/Al 2 O 3 , Ir/CaCO 3 , Pt/C, or a mixture thereof.

16. The process according to claim 1 , wherein the heterogeneous transition metal hydrogenation catalyst is Pd/C, Pd(OH) 2 /C, Au/TiO 2 , Rh/C, Ra—Ni or Pt/C.

17. The process according to claim 1 , wherein the heterogeneous transition metal hydrogenation catalyst is Pd/C or Ra—Ni.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2014
From: MAIR, HANS-JUERGEN; REENTS, REINHARD; SCALONE, MICHELANGELO; WANG, SHAONING; ZOGG, ANDRES
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 032278/0186 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2014
From: F. HOFFMANN-LA ROCHE AG
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 032278/0269 →
Priority Claims (1)
EP 10195294 · Dec 16, 2010 · regional
Continuity (2)
Division 13324199 · Dec 13, 2011
Related Publication 20140171502A1 · Jun 19, 2014